The results revealed the top three significantly enriched KEGG pathways, which were pathways in cancer (hsa05200), EGFR tyrosine kinase inhibitor resistance (hsa01521) and endocrine resistance (hsa01522). The gene discussed is EGFR; the disease is cancer.